Industrial Crops and Products, Год журнала: 2023, Номер 206, С. 117745 - 117745
Опубликована: Ноя. 3, 2023
Язык: Английский
Industrial Crops and Products, Год журнала: 2023, Номер 206, С. 117745 - 117745
Опубликована: Ноя. 3, 2023
Язык: Английский
Progress in Biophysics and Molecular Biology, Год журнала: 2025, Номер unknown
Опубликована: Июнь 1, 2025
Язык: Английский
Процитировано
0Particulate Science And Technology, Год журнала: 2025, Номер unknown, С. 1 - 11
Опубликована: Июнь 3, 2025
Язык: Английский
Процитировано
0Process Biochemistry, Год журнала: 2024, Номер 145, С. 229 - 242
Опубликована: Июнь 18, 2024
Язык: Английский
Процитировано
2Frontiers in Pharmacology, Год журнала: 2023, Номер 14
Опубликована: Сен. 21, 2023
Targeted immunotherapies have emerged as a transformative approach in cancer treatment, offering enhanced specificity to tumor cells, and minimizing damage healthy tissues. The targeted treatment of the immune system has become clinically applicable, demonstrating significant anti-tumor activity both early late-stage malignancies, subsequently enhancing long-term survival rates. most frequent therapies for are executed through utilization checkpoint inhibitor antibodies chimeric antigen receptor T cell treatment. However, when using immunotherapeutic drugs or combined treatments solid tumors like osteosarcoma, challenges arise due limited efficacy induction severe cytotoxicity. Utilizing nanoparticle drug delivery systems target tumor-associated macrophages bone marrow-derived suppressor cells is promising attractive approach. This because these marrow often exert immunosuppressive effects microenvironment, promoting progression, metastasis, development resistance. Moreover, given propensity myeloid engulf nanoparticles microparticles, they logical therapeutic targets. Therefore, we discussed mechanisms nanomedicine-based enhancement therapy targeting how related strategies well adapt immunotherapy from perspectives such immunogenic death with nanoparticles, regulating proportion various cellular subgroups macrophages, interaction ligands, activating immunostimulatory signaling pathways, altering epigenetics, modulating intensity immunostimulation. We also explored clinical implementations grounded on nanomedicine.
Язык: Английский
Процитировано
5Industrial Crops and Products, Год журнала: 2023, Номер 206, С. 117745 - 117745
Опубликована: Ноя. 3, 2023
Язык: Английский
Процитировано
5